ABSTRACT The studies reported herein were designed to determine the effects of allogeneic effect factor (AEF), a soluble mediator generated in the course of allogeneic cell interactions, on the differentiation of cytotoxic T lymphocytes in vitro.
phocytes in the absence of specific antigenic stimulation. The studies presented in this report illustrate the capacity of a soluble mediator, termed allogeneic effect factor (AEF), which is derived from histoincompatible cell interactions, to induce the in vitro differentiation of normal murine splenic lymphocytes into mature cytotoxic cells capable of exerting cytolytic activity on tumor target cells. This process requires the presence of T lymphocytes during the sensitization phase, and the lytic activity on tumor cells is mediated by cytotoxic T lymphocytes (CTL). The capacity of AEF to induce differentiation of such CTL does not require the presence of stimulating target cells in the sensitization phase and, moreover, the AEF-induced CTL manifest preferential cytolytic activity for tumor target cells that are H-2-identical and specificity in their cytolytic activity for the tumor target cells used.
The present investigation was derived from previous studies on AEF in this laboratory that primarily focused on the biological effects of AEF on in vitro antibody responses of murine B lymphocytes (1) . The latter studies demonstrated that AEF could augment antibody responses of untreated spleen cells and, moreover, replace the requirement for carrier-specific helper T cells as shown by its ability to reconstitute responses by T cell-depleted spleen cells. Other investigators reported similar effects of supernatants derived from mixed lymphocyte cultures (MLC, reviewed in ref. 2) , and observations on the biological activity of AEF described from this laboratory (1) have recently been confirmed by Delovitch and McDevitt (3) .
The capacity of MLC-derived supernatants to augment relatively weak in vitro sensitization of murine T lymphocytes to alloantigens on the surface of fibroblasts was first reported by one of us (A.A.) several years ago (4) . Based on our earlier results, we constructed a model for the induction of all alloantigen-specific CTL which can be summarized as follows:
Lymphocyte-defined antigens (5), such as those determined by the I region or the Mls locus, trigger allogeneic responder cells to proliferate, releasing in the process soluble products that can then act as helper factors to augment the induction of specific CTL (4) . This model was supported by the subsequent direct demonstrations of collaboration between two distinct subpopulations of T lymphocytes in the in vitro induction of alloantigen-specific CTL (6) . Subsequently, other investigators reported that MLC-derived soluble products can enhance weak CTL responses (7) (8) (9) (10) (11) (12) (13) (14) and suggested various versions of a "two-signal" model for the induction of alloantigen-reactive CTL (6, 15, 16) . More recently, it has been demonstrated directly that the helper factor(s) active in such systems are produced by T cells that are Ly-1+ and predominantly reactive against I-region alloantigens (13) .
In view of the extensive characterization that has already been made with AEF, both biologically and physicochemically, we felt that it was germane to conduct a thorough analysis of the effects of AEF on T cell differentiation, using AEF prepared according to the method that was originally described by this laboratory (17) . It Preparations of AEF. AEF was prepared as described (17) . Briefly, thymocyte suspensions were mixed with 1500-R-irradiated semiallogeneic or allogeneic spleen cell suspensions at a 1:1 ratio, and 108 cells of each were injected intravenously into 650-R-irradiated recipient mice syngeneic with the thymocyte donors (1 R = 2.58 X O-4 C/kg). The alloantigen-activated T cells recovered from the spleens of these mice 7 days later were cultured for 24 hr with fresh irradiated stimulator spleen cells identical to those used for the in vivo activation step. Cells were cultured at 1 X 107/ml each in RPMI-1640 supplemented with 0.1 mM 2-mercaptoethanol. In most experiments these cultures were carried out in serum-free medium; only on occasion did the culture medium contain 5% fetal calf serum. When AEF was prepared in serum-free conditions the responder and stimulator cells were pretreated with 10 Atg of phenylmethylAbbreviations: AEF, allogeneic effect factor; CTL, cytotoxic T lymphocytes; MLC, mixed lymphocyte culture. 3477
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sulfonyl fluoride per ml to inhibit the activity of serine proteases that apparently degrade the AEF (18) . Control supernatants were prepared in either one of two ways: (i) culturing the ATC in vitro with irradiated syngeneic spleen cells or (ii) culturing the ATC and the irradiated semiallogeneic or allogeneic stimulator cells in separate cultures and mixing the culture supernatants at a 1:1 ratio after harvesting the cultures. The cultures were harvested and the supernatant obtained by centrifugation at 2500 rpm for 15 min was filter-sterilized and kept at -700C until it was used. CTL Culture System. Spleen cell suspensions of normal, unprimed mice were prepared and depleted of their erythrocytes by NH4Cl treatment as described (19) . The cells were resuspended in Eagle-Hanks amino acid medium (20) supplemented with 50 ,M 2-mercaptoethanol and 5% heat-inactivated fetal calf serum and cultured in Cluster24 tissue culture plates (Microbiological Associates, Rockville, MD) at 7.5 X 106 cells per well in 2 ml of medium containing various concentrations of AEF as described in Results. The cultures were maintained for 5 days in a 5% CO2 incubator and then assayed for their cytolytic activity.
Cytolytic Assay. Target cells used in these experiments were the L (H_2k), EL4 (H-2b), and YAC (H-2a) tumor cell lines maintained in culture and the Thy-56 (H_2d) thymic lymphoma, kindly obtained from M. Vogt of the Salk Institute and maintained by in vivo passage as an ascitic tumor. Tumor cells (1.0 X 107) were labeled with 150 ,gCi of Na251CrO4 (New England Nuclear) for 1 hr, washed three times in medium containing 5% fetal calf serum at room temperature, and adjusted to 1 X 105 cells per ml. Sensitized spleen cells were harvested after 5 days of culture and washed, and several dilutions were prepared in fresh medium. One hundred microliters each of the effector and target cell suspensions were mixed in round-bottom wells of multi-well tissue culture plates (Linbro) and cultured in triplicate for 4-5 hr. Culture supernatants were harvested on a Titertek Supernatant Collection System (Skatron A.S., Lierbyen, Norway), and the specific lysis was calculated as described (19) .
Purification and Depletion of T Lymphocytes. T cellenriched spleen cells were obtained by purifying spleen cell suspensions on columns of nylon wool as described (21) . Less than 5% of these recovered cells stained positively with a fluorescent rabbit anti-mouse immunoglobulin, compared to 50-60% in unseparated spleen cell populations. T cells were depleted by treating spleen cell suspensions with anti-Thy 1.2 ascites or serum followed by guinea pig complement (C) as described (22) . Over 90% of such treated cells stained positively with rabbit anti-mouse immunoglobulin. The efficacy of the enrichment or depletion procedures described above was additionally verified by measuring responses of the various cell populations to phytohemagglutinin or lipopolysaccharide. Hydrocortisone-resistant thymocytes were obtained from mice injected 2-3 days previously with 2.5 mg of hydrocortisone intraperitoneally. The cell recovery from the thymus was 5-10%.
RESULTS

AEF Facilitates Primary In Vitro Sensitization of CAF1
Spleen Cells against Semisyngeneic Tumor Cells. Spleen cells from CAF1 mice were cultured either alone or in the presence of Thy-56 tumor cells in the absence or in the presence of various concentrations of AEF. Tumor-reactive CTL were assayed by their ability to lyse fresh Thy-56 target cells in a 51Cr release assay 5 were present or not. This failure to achieve primary induction of CTL against this tumor in vitro has been a consistent finding, although we are able to readily induce secondary CTL responses to Thy-56 in vitro by culturing spleen cells from tumor-immunized mice with mitomycin C-treated Thy-56 tumor cells for 5 Fig. 2 , the spleen cells cultured with AEF were markedly cytotoxic for Thy-56 (H-2d) and YAC (H-2a) target cells, both of which are H-2 compatible with the CAFI (H-2d/a) effector spleen cells. The level of cytotoxic activity was dependent on the strain combination used for the AEF preparation (Fig. 2) and on the concentration of AEF used (unpublished observation). Also illustrated in Fig. 2 Fig. 4 , was performed to ascertain whether such AEF-induced CTL exhibited any preference in cytolytic activity for H-2-identical, as opposed to H-2-dissimilar, target cells. Spleen cells from congenic B1O.D2 (H-2d) and BMO.BR (H-2k) mice were cultured for 5 days with AEF, and the resulting cytolytic activities in these respective cultures were tested in a 5ICr release assay against both H-2d (Fig. 4A ) and H-2k (Fig. 4B) (Fig. 4), C57BL/10 (H-2b) spleen cells cultured with AEF for 5 days produced a lysis of 8.9% and 16.0% against the Thy-56 and the L target cells, respectively, at an effectorto-target ratio of 60:1. These results readily demonstrate that the CTL induced by AEF exhibit marked preference for H-2-compatible targets. Similar results were obtained in other experiments of this type. However, in certain combinations of effector and target cells, this preference for H-2-compatible target cells was less clear, as was the case when lysis was tested against EL4 (H-2b) target cells. Effector cells of the same three haplotypes used in the experiment described in Fig. 4 produced the following levels of lysis against EL4 (H-2b) target cells: C57BL/10, 18.3%; BlO.D2, 13.4%; and B1O.BR, 16.2%. The cytolysis appeared to be specific since the lysis of a given target cell by such CTL could be most efficiently inhibited by the homologous unlabeled target cell in the unlabeled target inhibition assay (unpublished data).
DISCUSSION
Various soluble factors from allogeneic cell interactions, usually derived from in vitro MLCs, have been reported to facilitate the induction of antigen-specific CTL (4, (7) (8) (9) (10) (11) (12) (13) (14) . In addition, T cell mitogens or soluble products of mitogen-stimulated T cells produced similar effects (13, (23) (24) (25) (26) . In all of the aforementioned circumstances, the soluble factors used exerted their biological activities on T cells that were primed against cellular antigens (such as alloantigens) either prior to or simultaneously with their exposure to the soluble factor being studied. Heretofore, wherever this point has been specifically investigated, it was found that these soluble factors failed to exert activity on unprimed T cells not exposed to antigen (4, (7) (8) (9) (10) (11) (12) (13) (14) . The present study constitutes, therefore, a demonstration of the capacity of a soluble mediator derived from allogeneic cell interactions to stimulate and trigger unprimed murine T lymphocytes to differentiate into CTL in the absence of foreign stimulating target cells.
Thus, AEF that had been prepared in the same manner as originally described by this laboratory for earlier investigations of its biological activities on differentiating B lymphocytes was highly effective in inducing the development of cytolytic activity against appropriate tumor target cells. Cytotoxic lymphocytes did not develop in T cell-depleted spleen cultures exposed to AEF, and the cytolytic activity was mediated by T lymphocytes during the effector phase of the response. The AEF-induced CTL displayed obvious H-2 preference in terms of the extent of cytolytic activity exerted on 5lCr-labeled tumor target cells. It should be emphasized, nevertheless, that although cytolysis by such CTL was more efficient on tumor targets of the same H-2 type, they were still able to exert some cytolytic activity on H-2-dissimilar targets. Hence, these differences are best viewed as examples of syngeneic preference rather than restriction.
It should be stressed that the nature of the antigenic determinants recognized by the AEF-induced CTL is unknown, and it remains to be determined whether or not these actually are H-2 antigens or some other antigens recognized by the effector cells in association with self H-2 antigens.
The relationship of AEF to other similar factors affecting CTL differentiation in unclear. Certain differences are obvious immediately, however. First, as stated above, our AEF has exerted clear biological effects on murine lymphocytes that were unprimed and not otherwise exposed to stimulating target cell antigens. Second, whereas the factors described by others primarily affected the differentiation of CTL, apparently without being mitogenic for T lymphocytes, we have recently found that the AEF used in the system described here is highly mitogenic for T lymphocytes (unpublished data). This is in agreement with a recent report documenting the mitogenic effect of xenogeneic reconstitution factor, a soluble mediator derived from human MLC, on normal murine thymocytes (27) . This could imply that our AEF contains one or more additional active moieties that may be missing from the other "helper" factors that have been similarly studied (4, (7) (8) (9) (11) (12) (13) (14) (15) (16) .
It is pertinent to point out that at least some of the reasons for differences in the biological activities displayed by various MLC-derived soluble mediators may be related to the different methodologies used for preparation of these factors. For example, Delovitch and McDevitt (3) recently reported a genetically restricted AEF which was prepared by activating thymocytes in irradiated allogeneic recipients, followed by a short-term in vitro MLC. Although similar in many respects to the method that we originally described (17) (29, 30) . These findings do not fully explain our present results, however, since the autonomous induction of CTL did not occur in fresh medium alone (which contained fetal calf serum and 2-mercaptoethanol) or in medium supplemented with a control supernatant. The induction of CTL in these cultures was strictly dependent on the presence of AEF.
The mechanism by which AEF induces the development of CTL as described in these experiments is not fully understood. However, our results exclude the possibility that shed alloantigens carried over into the culture in the AEF preparation are responsible for triggering an antigen-specific CTL response. In the experiment presented in Fig. 2 Fig. 4 would have resulted in the lysis of L and Thy-56 target cells, respectively, and, in fact, this was clearly not the case.
One attractive possibility that is currently being tested is that the biologically active entity in AEF, similar to "helper" factors described by others (4, (7) (8) (9) (10) (11) (12) (13) (14) , facilitates the induction of autoreactive CTL clones. It was reported recently that in the absence of a proliferative stimulus providing "help," suppressor cells can be induced in a human MLC (35) . Thus, the mitogenic stimulus provided by the AEF may overcome suppressor T cells that normally regulate autosensitization (36) and thereby allow the development of autoreactive CTL. This possibility is sup-ported by our recent finding that an allogeneic effect, in the form of irradiated allogeneic spleen cells, can partially reverse the suppression of a secondary tumor-specific CTL response in vitro mediated by thymocytes of tumor-bearing mice (unpublished data).
